What’s New in Prostate Cancer
Efficacy and Safety of Darolutamide in Combination With ADT and Docetaxel by Disease Volume and Disease Risk in the Phase 3 ARASENS Study
By
ASCO GU 2023 Conference Coverage
FEATURING
Cora Sternberg
By
ASCO GU 2023 Conference Coverage
FEATURING
Cora Sternberg
Login to view comments.
Click here to Login
What’s New in Prostate Cancer